SUMMARY In order to evaluate the incidence and aetiology of hypergastrinaemia 53 patients with seropositive rheumatoid arthritis were examined for gastric acid secretion, fasting serum gastrin concentration, circulating parietal cell antibodies, and some parameters of the activity of inflammation of rheumatoid arthritis. The basal and maximum acid output was found to be subnormal in this group (P<O01), and in 11 of these patients (23 %) the fasting serum gastrin levels were raised (P<0 05). This hypergastrinaemia correlated strongly with maximum acid output. Only in cases of achlorhydria or hypochlorhydria (maximum acid output less than 2 mmol/l) was the serum gastrin level markedly raised. Two out of 5 patients with achlorhydria were found to have circulating parietal cell antibodies, and 1 had decreased absorption of vitamin B12. No relationship was found between serum gastrin and duration or activity of rheumatoid arthritis; nor was there a relationship between basal serum gastrin and the various antirheumatic drugs administered.
have demonstrated a high incidence of hypergastrinaemia in patients with rheumatoid arthritis (RA). But the cause of this phenomenon was not established. The inflammatory activity, the duration of the rheumatoid arthritis, and the gastric acid secretion were found to be unrelated to serum gastrin levels, nor did the presence of rheumatoid factor in serum influence the serum gastrin levels (Rooney et al., 1976a (Rooney et al., , 1976b . We have therefore investigated the incidence and the possible causes of the increased fasting serum gastrin levels in patients with rheumatoid arthritis.
Patients and methods
Fifty-three patients were included in this study.
28 females and 25 males with a mean age of 55 years (range 17-74 years). All patients met the criteria of the American Rheumatism Association for the diagnosis of classical or definite rheumatoid arthritis (Ropes et al., 1959 Fasting serum gastrin was measured by a radioimmunoassay technique (Stadil and Rehfeld, 1973; Lamers and van Tongeren, 1977) . The gastrin antiserum was raised in a rabbit against synthetic human gastrin I containing residues 2 through 17 (SHG 2-17, Imperial Chemical Industries Ltd.) conjugated to bovine albumin. Gastrin components I, 1:1 (gastrin-34), m (gastrin-17), and IV (gastrin-13) could be demonstrated by using this antibody. The antibody reacted with sulphated and nonsulphated forms of gastrins I, I, and m with almost equimolar potency (Rehfeld et al., 1975) .
Gastric contents were collected according to the method of Hector (1968) ; the correct position of the orogastric tube in the stomach was checked by the water recovery test (Hassan, and Hobsley 1970 (Nienhuis and Mandema, 1963) . The following parameters of inflammatory activity were recorded: erythrocyte sedimentation rate (ESR), haemoglobin, and protein electrophoresis.
Statistical analyses were carried out by the Wilcoxon test for unpaired data. Regression analyses were done by the method of least squares.
Results
In 11 out of the 53 patients investigated fasting serum gastrin levels were raised, while none were raised in the 28 matched controls. The serum gastrin level of the whole group, 158 pg/ml (range 44-790 pg/ml), was significantly (P <0 05) higher than in the matched control group, 67 pg/ml (range 43-97 pg/ml). As shown in Table 1 , the basal gastric acid output, maximum acid output, and maximum acid concentration were significantly (P < 0.01) lower than in a group of 20 healthy persons. This population was subdivided into 5 different groups in accordance with the MAO, namely, total achlorhydria (group A); severe hypochlorhydria, MAO 0-2 mmol/h (group B); mild hypochlorhydria, MAO 2-6 mmol/h (group C); moderate hypochlorhydria, MAO 6-10 mmol/h (group D); and MAO more than 10 mmol/h (group E) (Fig. 1) . Markedly increased serum gastrin concentrations were found almost exclusively in patients with achlorhydria (group A) or severe hypochlorhydria (group B). These patients had significantly (P < 0 02) higher serum gastrin levels than patients in groups C, D, and E. Group A showed a weak tendency for higher gastrin levels than group B (P=0 1). Two out of 5 patients with achlorhydria had parietal cell antibodies, and none had demonstrable antibodies against intrinsic factor. Only 1 patient showed an impaired absorption of vitamin B12 (2 * 3 % excretion of labelled vitamin B12 in 48-hours urine; normal more than 15% in 48-hours), but this patient had no evidence of pernicious anaemia. None of the other patients had demonstrable circulating parietal cell or intrinsic factor antibodies.
In the RA patients with MAO more than 2 mmol/h there was no significant correlation between BAO and serum gastrin (r=0 *22) and between MAO and serum gastrin (r=0-03). Furthermore, we found no correlation between the serum gastrin level and the age of the patients, duration of the rheumatoid arthritis, articular joint index, subcutaneous nodules, ESR, haemoglobin, antiperinuclear antibodies, and antinuclear antibodies. As shown in Fig. 2 , no relation was found between serum gastrin levels and the various antirheumatic drugs used. group.bmj.com on October 14, 2017 -Published by http://ard.bmj.com/ Downloaded from Gastrin (pg /ml) serum gastric concentration (Trudeau and Mca04 Guigan, 1971; Gedda-Dahl, 1974) . The increased Achlorhydria serum gastrin levels in these conditions are caused by x M A 0. < 2 m mol / h the lack of inhibition of antral gastrin release due to the absence of gastric acid (Yalow and Berson, 1970; Fahrenkrug et al., 1976) .
In and hypochlorhydria or achlorhydria in 60% of a group of 50 rheumatoid patients. We abstained from Discussion taking gastric biopsies in our patients because it was considered unjustifiable to perform this procedure In a group of 53 patients with seropositive, definite for experimental reasons only. Moreover, a small or classical, rheumatoid arthritis a high frequency sample biopsy cannot conclusively exclude the of hypergastrinaemia (23%) has been established. presence of chronic atrophic gastritis. Atrophic This is in accordance with the findings of Rooney gastritis, as demonstrated by others, resulting in a et al. (1973a, 1973b, 1976a, 1976b) . Whereas these low gastric acid secretion can be accounted for authors found normal gastric acid output in almost either by the rheumatoid arthritis itself or by all of their 16 RA patients with hypergastrinaemia, the long-term administration of anti-inflammatory according to our data this hypergastrinaemia in drugs. rheumatoid patients appears to be based on an
In the present study no relation was found betabsence or severe reduction of gastric acid secretion. ween gastric acid secretion and the antirheumatic There is no ready explanation for the discrepancy drugs given. Although in both studies no relation between the findings of Rooney et al. (1976b) and was found between the hyposecretion of gastric our own results, although in contrast to our study acid and the duration or activity of the rheumatic Rooney and coworkers did not include rheumatoid process, a possible role of the rheumatoid arthritis patients with normal serum gastrin levels in their itself in the development of the hypochlorhydria study. Nor did they show whether there is any cannot be excluded. Moreover, the increase of serum relationship between serum gastrin levels and gastrin levels in untreated adjuvant arthritis in the gastric acid secretion in their hypergastrinaemic rat also indicates a causative role of the inflammatory patients. Generally, serum gastrin levels are in-process itself (Rooney et al., 1973c) . creased in patients with reduced gastric production In conclusion, the high incidence of hypergas- (Walsh and Grossman, 1975) . Moreover, in patients trinaemia in patients with RA is, in our opinion with hypochlorhydria there is an inverse correlation due to achlorhydria or severe hypochlorhydria, and between stimulated acid secretion rate and fasting probably is the result of chronic atrophic gastritis.
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